BioPlus Acquisition Corp.

NASDAQ: BIOS · Real-Time Price · USD
10.79
-0.01 (-0.09%)
At close: Oct 06, 2023, 7:46 PM

BioPlus Acquisition Statistics

Share Statistics

BioPlus Acquisition has - shares outstanding. The number of shares has increased by 0% in one year.

n/a
0%
0%
n/a
n/a
100
0.28%

Short Selling Information

n/a
n/a
n/a
n/a

Valuation Ratios

The PE ratio is 1183.3 and the forward PE ratio is null. BioPlus Acquisition's PEG ratio is -8.53.

1183.3
n/a
0
n/a
27.4
-8835.49
-8.53
Financial Ratio History

Enterprise Valuation

BioPlus Acquisition has an Enterprise Value (EV) of 6.11B.

0
-5220.56
-8842.52
-8842.52

Financial Position

The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.02.

1.04
1.04
0.02
-4.27
-7.23
0.37

Financial Efficiency

Return on Equity is 2.32% and Return on Invested Capital is -1.33%.

2.32%
2.17%
-1.33%
n/a
n/a
undefined
0
n/a

Taxes

-3.17M
-158.68%

Stock Price Statistics

The stock price has increased by -0.09% in the last 52 weeks. The beta is 0, so BioPlus Acquisition's price volatility has been lower than the market average.

0
-0.09%
10.77
10.54
51.09
35,934

Income Statement

n/a
-1.17M
-1.17M
5.16M
-1.17M
n/a
0.01
Full Income Statement

Balance Sheet

The company has 140.3K in cash and 5M in debt, giving a net cash position of -4.86M.

140.3K
5M
-4.86M
-14.78M
138.63M
-1.78M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -691.47K and capital expenditures 0, giving a free cash flow of -691.47K.

-691.47K
n/a
-691.47K
0
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

BIOS does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
0.08%
-0.01%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for BIOS.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

7.26
3